First Trust Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.2M | Buy |
352,315
+182,047
| +107% | +$15M | 0.02% | 786 |
|
|
2025
Q4 | $14.5M | Buy |
170,268
+42,974
| +34% | +$3.53M | 0.01% | 966 |
|
|
2025
Q3 | $9.9M | Sell |
127,294
-33,056
| -21% | -$2.58M | 0.01% | 1096 |
|
|
2025
Q2 | $12.5M | Sell |
160,350
-8,739
| -5% | -$652K | 0.01% | 1020 |
|
|
2025
Q1 | $12.3M | Sell |
169,089
-101,522
| -38% | -$7.27M | 0.01% | 991 |
|
|
2024
Q4 | $20M | Buy |
270,611
+108,057
| +66% | +$7.56M | 0.02% | 862 |
|
|
2024
Q3 | $10.7M | Sell |
162,554
-127,426
| -44% | -$9.26M | 0.01% | 1022 |
|
|
2024
Q2 | $26.8M | Buy |
289,980
+271,632
| +1,480% | +$24.1M | 0.03% | 682 |
|
|
2024
Q1 | $1.75M | Buy |
18,348
+5,614
| +44% | +$472K | ﹤0.01% | 1792 |
|
|
2023
Q4 | $971K | Sell |
12,734
-84,089
| -87% | -$5.85M | ﹤0.01% | 1974 |
|
|
2023
Q3 | $6.71M | Buy |
96,823
+90,927
| +1,542% | +$7.31M | 0.01% | 1110 |
|
|
2023
Q2 | $556K | Buy |
5,896
+528
| +10% | +$45.9K | ﹤0.01% | 2113 |
|
|
2023
Q1 | $444K | Sell |
5,368
-15,584
| -74% | -$1.22M | ﹤0.01% | 2164 |
|
|
2022
Q4 | $1.56M | Sell |
20,952
-98,710
| -82% | -$7.61M | ﹤0.01% | 1806 |
|
|
2022
Q3 | $9.89M | Sell |
119,662
-143,648
| -55% | -$13.8M | 0.01% | 950 |
|
|
2022
Q2 | $25M | Buy |
263,310
+8,741
| +3% | +$905K | 0.03% | 625 |
|
|
2022
Q1 | $30M | Sell |
254,569
-39,312
| -13% | -$4.41M | 0.03% | 652 |
|
|
2021
Q4 | $38.1M | Buy |
293,881
+141,180
| +92% | +$16.5M | 0.04% | 582 |
|
|
2021
Q3 | $17.3M | Sell |
152,701
-1,656,824
| -92% | -$189M | 0.02% | 833 |
|
|
2021
Q2 | $187M | Buy |
1,809,525
+1,686,487
| +1,371% | +$159M | 0.2% | 127 |
|
|
2021
Q1 | $10.3M | Sell |
123,038
-46,466
| -27% | -$3.93M | 0.01% | 927 |
|
|
2020
Q4 | $15.5M | Buy |
169,504
+49,976
| +42% | +$4.15M | 0.02% | 697 |
|
|
2020
Q3 | $9.54M | Sell |
119,528
-1,400,820
| -92% | -$109M | 0.02% | 755 |
|
|
2020
Q2 | $105M | Buy |
1,520,348
+991,328
| +187% | +$70.5M | 0.18% | 132 |
|
|
2020
Q1 | $33.3M | Buy |
529,020
+24,780
| +5% | +$1.79M | 0.08% | 404 |
|
|
2019
Q4 | $39.2M | Buy |
504,240
+362,514
| +256% | +$28.3M | 0.07% | 442 |
|
|
2019
Q3 | $10.4M | Sell |
141,726
-343,539
| -71% | -$24.1M | 0.02% | 804 |
|
|
2019
Q2 | $29.9M | Sell |
485,265
-237,321
| -33% | -$14.4M | 0.06% | 445 |
|
|
2019
Q1 | $46.1M | Sell |
722,586
-34,083
| -5% | -$1.95M | 0.09% | 281 |
|
|
2018
Q4 | $38.6M | Buy |
756,669
+339,165
| +81% | +$17.2M | 0.09% | 276 |
|
|
2018
Q3 | $24.2M | Sell |
417,504
-677,148
| -62% | -$33.1M | 0.05% | 533 |
|
|
2018
Q2 | $53.1M | Buy |
1,094,652
+945,432
| +634% | +$44.1M | 0.11% | 199 |
|
|
2018
Q1 | $6.94M | Sell |
149,220
-7,974
| -5% | -$346K | 0.02% | 893 |
|
|
2017
Q4 | $5.91M | Sell |
157,194
-466,944
| -75% | -$17.1M | 0.01% | 963 |
|
|
2017
Q3 | $22.7M | Buy |
+624,138
| New | +$23.8M | 0.06% | 445 |
|
|
2017
Q2 | – | Sell |
-202,209
| Closed | -$6.34M | – | 2394 |
|
|
2017
Q1 | $6.34M | Sell |
202,209
-614,751
| -75% | -$19.2M | 0.02% | 948 |
|
|
2016
Q4 | $25.5M | Sell |
816,960
-305,475
| -27% | -$9.9M | 0.08% | 348 |
|
|
2016
Q3 | $45.1M | Sell |
1,122,435
-76,644
| -6% | -$2.89M | 0.13% | 151 |
|
|
2016
Q2 | $39.9M | Sell |
1,199,079
-90,864
| -7% | -$3.11M | 0.13% | 171 |
|
|
2016
Q1 | $37.9M | Sell |
1,289,943
-1,721,025
| -57% | -$47.5M | 0.12% | 193 |
|
|
2015
Q4 | $79.3M | Buy |
3,010,968
+890,622
| +42% | +$23.1M | 0.21% | 110 |
|
|
2015
Q3 | $50.2M | Sell |
2,120,346
-1,542,324
| -42% | -$37.2M | 0.15% | 146 |
|
|
2015
Q2 | $86.9M | Sell |
3,662,670
-396,654
| -10% | -$8.95M | 0.23% | 93 |
|
|
2015
Q1 | $96.4M | Buy |
4,059,324
+907,692
| +29% | +$20.4M | 0.28% | 69 |
|
|
2014
Q4 | $66.9M | Sell |
3,151,632
-286,884
| -8% | -$5.76M | 0.23% | 88 |
|
|
2014
Q3 | $58.5M | Buy |
3,438,516
+2,528,616
| +278% | +$39.9M | 0.23% | 83 |
|
|
2014
Q2 | $13M | Buy |
909,900
+512,922
| +129% | +$6.95M | 0.05% | 539 |
|
|
2014
Q1 | $4.91M | Buy |
+396,978
| New | +$4.58M | 0.02% | 975 |
|
Other funds holding EW
VCM
VPM
First Trust Advisors's EW Position: Q1 2026 in Review
First Trust Advisors increased its Edwards Lifesciences (EW) stake by 107% in Q1 2026, buying an estimated $15M and bringing the position to 352,315 shares worth $28.2M. The position accounts for 0.02% of the portfolio, ranked #786.
First Trust Advisors first reported a position in EW in Q1 2014 and has held it in 48 quarters since. The position peaked at $187M in Q2 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- First Trust Advisors held 352,315 shares of Edwards Lifesciences worth $28.2M as of Q1 2026.
- First Trust Advisors bought 182,047 Edwards Lifesciences shares in Q1 2026, an estimated $15M.
- Edwards Lifesciences made up 0.02% of First Trust Advisors's portfolio in Q1 2026, its #786 holding.
- First Trust Advisors first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 48 quarters since.
- First Trust Advisors's Edwards Lifesciences position peaked at $187M in Q2 2021.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.